Announcement
27 Apr 2026
: M42’s Danat Al Emarat Introduces Advanced Keyhole Surgery to Treat Spina Bifida Before Birth

Advancing the Future of Health

M42 combines clinical excellence with AI, advanced technology and genomics to disrupt traditional healthcare models and scale health solutions to serve patients, populations and national systems. Our global network supports our ambition to build a globally-scaled health intelligence platform that improves patient outcomes, expands access and drives measurable impact for communities worldwide.

Markets We Serve

M42 is a global health leader advancing precision, prevention and prediction in health. Headquartered in Abu Dhabi, it operates across key international markets, scaling innovation, enabling collaboration and delivering measurable health impact. Today, its network spans more than 480 facilities across 27 countries.

Middle East

A market-leading hub anchored in Abu Dhabi, delivering advanced, integrated healthcare and driving innovation across the region.

  • Saudi Arabia
  • United Arab Emirates
  • Bahrain

Europe

A strong presence across diverse markets enabling specialized care, research collaboration and cross-border innovation.

  • Albania
  • France
  • Germany
  • Greece
  • Hungary
  • Italy
  • Lithuania
  • North Macedonia
  • Poland
  • Portugal
  • Romania
  • Russia
  • Spain
  • Sweden
  • United Kingdom

South America

A strong presence across diverse markets enabling specialized care, research collaboration and cross-border innovation.

  • Brazil
  • Chile
  • Uruguay

Asia

A strategic growth market where M42 is scaling data-driven, technology-led healthcare and accelerating innovation.

  • China
  • Kazakhastan
  • Malaysia
  • Singapore

North Africa

M42 is expanding its presence by combining strategic partnerships with AI-powered, data-driven solutions to advance diagnostics, research and patient care.

  • Morocco